|
1
|
Yi B, Zhang M, Schwartz-Albiez R and Cao
Y: Mechanisms of the apoptosis induced by CD176 antibody in human
leukemic cells. Int J Oncol. 38:1565–1573. 2011.PubMed/NCBI
|
|
2
|
Manzotti G, Mariani SA, Corradini F,
Bussolari R, Cesi V, Vergalli J, Ferrari-Amorotti G, Fragliasso V,
Soliera AR, Cattelani S, et al: Expression of p89 (c-Mybex9b), an
alternatively spliced form of c-Myb, is required for proliferation
and survival of p210BCR/ABL-expressing cells. Blood Cancer J.
2:e712012. View Article : Google Scholar
|
|
3
|
Thapalia BA, Zhou Z and Lin X: Autophagy,
a process within reperfusion injury: An update. Int J Clin Exp
Pathol. 7:8322–8341. 2014.
|
|
4
|
Huang Z, Ye B, Dai Z, Wu X, Lu Z, Shan P
and Huang W: Curcumin inhibits autophagy and apoptosis in
hypoxia/reoxygenation-induced myocytes. Mol Med Rep. 11:4678–4684.
2015.PubMed/NCBI
|
|
5
|
Su X, Wang X, Liu Q, Wang P, Xu C and
Leung AW: The role of Beclin 1 in SDT-induced apoptosis and
autophagy in human leukemia cells. Int J Radiat Biol. 91:472–479.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Manfredi MG, Ecsedy JA, Chakravarty A,
Silverman L, Zhang M, Hoar KM, Stroud SG, Chen W, Shinde V, Huck
JJ, et al: Characterization of Alisertib (MLN8237), an
investigational small-molecule inhibitor of aurora A kinase using
novel in vivo pharmacodynamic assays. Clin Cancer Res.
17:7614–7624. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Niu NK, Wang ZL, Pan ST, Ding HQ, Au GH,
He ZX, Zhou ZW, Xiao G, Yang YX, Zhang X, et al: Pro-apoptotic and
pro-autophagic effects of the Aurora kinase A inhibitor alisertib
(MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the
activation of mitochondria-mediated pathway and inhibition of p38
MAPK/PI3 K/Akt/mTOR signaling pathway. Drug Des Devel Ther.
9:1555–1584. 2015.
|
|
8
|
Bunaciu RP, Tang T and Mao CD:
Differential expression of Wnt13 isoforms during leukemic cell
differentiation. Oncol Rep. 20:195–201. 2008.PubMed/NCBI
|
|
9
|
Wang Y, Lin Z, Huang H, He H, Yang L, Chen
T, Yang T, Ren N, Jiang Y, Xu W, et al: AMPK is required for
PM2.5-induced autophagy in human lung epithelial A549 cells. Int J
Clin Exp Med. 8:58–72. 2015.PubMed/NCBI
|
|
10
|
Qi W, Spier C, Liu X, Agarwal A, Cooke LS,
Persky DO, Chen D, Miller TP and Mahadevan D: Alisertib (MLN8237)
an investigational agent suppresses Aurora A and B activity,
inhibits proliferation, promotes endo-reduplication and induces
apoptosis in T-NHL cell lines supporting its importance in PTCL
treatment. Leuk Res. 37:434–439. 2013. View Article : Google Scholar
|
|
11
|
Melichar B, Adenis A, Lockhart AC,
Bennouna J, Dees C, Kayaleh O, Obermannova R, DeMichele A,
Zatloukal P, Zhang B, et al: Safety and activity of alisertib, an
investigational aurora kinase A inhibitor, in patients with breast
cancer, small-cell lung cancer, non-small-cell lung cancer, head
and neck squamous-cell carcinoma, and gastro-oesophageal
adenocarcinoma: A five-arm phase 2 study. Lancet Oncol. 16:395–405.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Wu K, Xiao X, Liao J, Hu Q, Chen
H, Liu J and An X: Autophagy as a regulatory component of
erythropoiesis. Int J Mol Sci. 16:4083–4094. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moon HS, Kim B, Gwak H, Suh DH and Song
YS: Autophagy and protein kinase RNA-like endoplasmic reticulum
kinase (PERK)/eukaryotic initiation factor 2 alpha kinase (eIF2α)
pathway protect ovarian cancer cells from metformin-induced
apoptosis. Mol Carcinog. Feb 7–2015.Epub ahead of print.
|
|
14
|
Condello M, Caraglia M, Castellano M,
Arancia G and Meschini S: Structural and functional alterations of
cellular components as revealed by electron microscopy. Microsc Res
Tech. 76:1057–1069. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Krampe S and Boles E: Starvation-induced
degradation of yeast hexose transporter Hxt7p is dependent on
endocytosis, autophagy and the terminal sequences of the permease.
FEBS Lett. 513:193–196. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lamark T and Johansen T: Autophagy: Links
with the proteasome. Curr Opin Cell Biol. 22:192–198. 2010.
View Article : Google Scholar
|
|
17
|
Wang F, Li H, Yan XG, Zhou ZW, Yi ZG, He
ZX, Pan ST, Yang YX, Wang ZZ, Zhang X, et al: Alisertib induces
cell cycle arrest and autophagy and suppresses
epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and
sirtuin 1-mediated signaling pathways in human pancreatic cancer
cells. Drug Des Devel Ther. 9:575–601. 2015.PubMed/NCBI
|
|
18
|
Ding YH, Zhou ZW, Ha CF, Zhang XY, Pan ST,
He ZX, Edelman JL, Wang D, Yang YX, Zhang X, et al: Alisertib, an
Aurora kinase A inhibitor, induces apoptosis and autophagy but
inhibits epithelial to mesenchymal transition in human epithelial
ovarian cancer cells. Drug Des Devel Ther. 9:425–464.
2015.PubMed/NCBI
|
|
19
|
Jung CH, Kim H, Ahn J, Jung SK, Um MY, Son
KH, Kim TW and Ha TY: Anthricin Isolated from Anthriscus sylvestris
(L.) Hoffm. Inhibits the growth of breast cancer cells by
inhibiting Akt/mTOR signaling and its apoptotic effects are
enhanced by autophagy inhibition. Evid Based Complement Alternat
Med. 2013:3852192013. View Article : Google Scholar
|
|
20
|
Badura S, Tesanovic T, Pfeifer H, Wystub
S, Nijmeijer BA, Liebermann M, Falkenburg JH, Ruthardt M and
Ottmann OG: Differential effects of selective inhibitors targeting
the PI3K/AKT/mTOR pathway in acute lymphoblastic leukemia. PLoS
One. 8:e800702013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qin L, Wang Z, Tao L and Wang Y: ER stress
negatively regulates AKT/TSC/mTOR pathway to enhance autophagy.
Autophagy. 6:239–247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vakana E, Sassano A and Platanias LC:
Induction of autophagy by dual mTORC1-mTORC2 inhibition in
BCR-ABL-expressing leukemic cells. Autophagy. 6:966–967. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuan CX, Zhou ZW, Yang YX, He ZX, Zhang X,
Wang D, Yang T, Wang NJ, Zhao RJ and Zhou SF: Inhibition of mitotic
Aurora kinase A by alisertib induces apoptosis and autophagy of
human gastric cancer AGS and NCI-N78 cells. Drug Des Devel Ther.
9:487–508. 2015.PubMed/NCBI
|
